跳至主要内容
临床试验/NL-OMON37433
NL-OMON37433已完成不适用

Optimizing orthotic management in children with cerebral palsy to improve mobility and participation - AFO efficacy in Cerebral Palsy

Vrije Universiteit Medisch Centrum0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • - children diagnosed with spastic Cerebral Palsy
  • - children aged between 6 and 14 years
  • - a gait pattern that is characterized by excessive knee flexion
  • - Gross motor function classification score (GMFCS) I - III, provided that the patient is able perform a 3D-gait analysis without walking aids
  • - ability to walk independently for at least five minutes at a comfortable walking speed (CWS).

排除标准

  • - orthopaedic surgery or other surgical interventions that might influence mobility in the past 6 months
  • - Botulinum Toxin A injections in the past three months
  • - intrathecal Baclofen (ICB) therapy in the last six months or selective dorsal rhizotomy (SDR) in the past year
  • - impairments that contra indicate fitness tests
  • - severe joint contractures
  • - severe behavioural problems

研究者

相似试验

Optimizing orthotic management in children with... | 临床试验